Manufacturing Expertise Recombinant Proteins
Recombinant proteins often require precise control of folding and post-translational modifications to maintain therapeutic function and stability. Avid leverages mammalian cell culture systems and disciplined process development to support consistent, scalable recombinant protein manufacturing.
Overview
Recombinant Protein Manufacturing
Built for Complexity
Key Recombinant Protein Development & Manufacturing Considerations
- Post-translational modification control
- Protein folding integrity
- Formulation Development
- Scalable purification processes
- Expression yield and stability
How Avid Supports Recombinant Protein Programs
- Mammalian cell line development
- Formulation Development
- Process characterization
- Analytical development
- Clinical and commercial manufacturing
- Regulatory lifecycle support
Solutions
Explore Our Solutions
Learn More
Recombinant Protein FAQs
Yes, when supported by validated upstream and downstream processes.
Controlling protein folding, post-translational modifications, and batch yield are central to successful production.
Advance Your Recombinant
Protein Program with Confidence
Connect with our team to discuss development timelines, manufacturing strategy, and
scalable CGMP production.